Best Weight Loss Medication In UK - Guide | Cured Pharmacy

Best Weight Loss Medication In UK

Mounjaro Weight Loss Injections (Tirzepatide) KwikPen

Featured Product

Mounjaro Weight Loss Injections (Tirzepatide) KwikPen

£145.00UK-based prescribers · Discreet delivery · Free private prescription
Start Assessment →✓ Lowest price guarantee
DISCOUNT CODE: FIRST20

£20 off for new patients

Tarun Kumar, Prescribing Pharmacist at Cured Pharmacy

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Reviewed on: 22 June 2026

Last Updated: 12 August 2026

Losing weight in the UK has never felt more medically supported than it does right now, and that is largely thanks to a wave of genuinely effective prescription options that have arrived over the past few years. Whether you have been struggling to shift stubborn weight for years, have been told by your GP that your BMI is putting your health at risk, or you have simply reached a point where diet and exercise alone are not delivering the results you need, understanding your medication options in 2026 is a powerful first step.

Quick Summary

The UK now has several clinically proven weight loss medications available, ranging from injectable GLP-1 and dual GIP/GLP-1 receptor agonists to oral fat-absorption blockers. The right treatment for you depends on your BMI, existing health conditions, and personal preferences around method of administration and cost.

  • Mounjaro (tirzepatide) is currently considered the most effective licensed weight loss injection in the UK
  • Wegovy (semaglutide) and Saxenda (liraglutide) are MHRA-approved injectable options with strong evidence
  • Orlistat is the main oral prescription option and is also available over the counter as Alli
  • Eligibility for NHS treatment typically requires a BMI of 35 or above with a weight-related condition
  • Private online clinics like Cured Pharmacy offer accessible routes to prescription treatment with UK-based prescribers

Weight Loss Timeline Estimator

Enter your details below to estimate how long it might take to reach your target weight with medication support. This is a general guide only and not medical advice.

Table of Contents

What Is Weight Loss Medication and Who Can Use It in the UK?

Weight loss medication refers to a category of licensed pharmaceutical treatments that work alongside dietary changes and physical activity to help people lose and maintain a reduced body weight. In the UK, these treatments are regulated by the Medicines and Healthcare products Regulatory Agency (MHRA), and prescriptions are issued by qualified clinicians based on clinical eligibility criteria. The idea that weight loss is simply a matter of willpower is outdated and unsupported by science. Obesity is now recognised as a chronic, complex condition influenced by genetics, hormones, environment, and psychology — and medication can be a legitimate and life-changing part of managing it.

To be eligible for prescription weight loss treatment in the UK, you generally need to meet one of the following criteria:

  • A BMI of 30 or above for private prescriptions through licensed online clinics
  • A BMI of 35 or above for NHS specialist referral, alongside at least one weight-related health condition such as type 2 diabetes, high blood pressure, or sleep apnoea
  • Documented evidence that lifestyle changes alone have not produced adequate results over a sustained period
  • No contraindications such as active eating disorders, certain thyroid conditions, or pregnancy

If you are unsure whether you qualify, a short online assessment with a registered prescriber is the quickest and most accurate way to find out. The assessment will review your medical history, current medications, and goals before recommending a treatment plan tailored to you.

The Best Weight Loss Medication UK Options Compared

There are now several MHRA-approved weight loss medications available in the UK, each working through a different mechanism and suited to different patients. The landscape has changed significantly since 2021, and 2026 sees tirzepatide firmly at the top of clinical rankings for efficacy. Understanding the key options helps you make an informed decision rather than simply picking the most talked-about one on social media.

Here is a breakdown of the main prescription options currently available:

  • Mounjaro (tirzepatide) – weekly injection, dual GIP/GLP-1 receptor agonist, up to 22.5% body weight reduction in trials
  • Wegovy (semaglutide 2.4mg) – weekly injection, GLP-1 receptor agonist, up to 15% body weight reduction
  • Saxenda (liraglutide 3mg) – daily injection, GLP-1 receptor agonist, up to 8% body weight reduction
  • Orlistat 120mg (prescription) – oral capsule taken with meals, reduces dietary fat absorption by up to 30%
  • Alli 60mg (over the counter) – lower-dose orlistat available without a prescription for adults with a BMI over 28

Each of these medications works through a distinct biological pathway. The injectable GLP-1 and GIP agonists reduce appetite by mimicking gut hormones that signal satiety to the brain, slowing gastric emptying and lowering calorie intake naturally. Orlistat takes a completely different approach by blocking the enzyme lipase in the gut, preventing around a third of dietary fat from being absorbed. Neither approach is a magic pill — all work best alongside a reduced-calorie diet and regular physical activity.

Mounjaro (Tirzepatide): The Most Effective Option Available in 2026

Mounjaro, the brand name for tirzepatide manufactured by Eli Lilly, is the most clinically effective licensed weight loss medication currently available in the UK. It was approved by the MHRA for weight management in adults with obesity in November 2023, and its uptake among UK patients has been remarkable. Unlike semaglutide-based treatments, tirzepatide acts on two hormone receptors simultaneously — glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). This dual action is believed to be why it outperforms single-receptor agonists in head-to-head data.

The landmark SURMOUNT-1 trial, published in the New England Journal of Medicine, demonstrated that participants using tirzepatide 15mg weekly lost an average of 22.5% of their body weight over 72 weeks — equivalent to roughly 23kg for someone starting at 105kg. These are results that were previously only associated with bariatric surgery. For many people dealing with the physical, psychological, and social burden of obesity, this level of weight loss is genuinely transformative.

Key features of Mounjaro as a weight loss treatment include:

  • Once-weekly subcutaneous injection using the KwikPen device — no needles to handle separately
  • Dose titration starting at 2.5mg, escalating gradually up to 15mg to reduce side effects
  • Significant improvements in blood glucose, blood pressure, and cardiovascular risk markers
  • Well-studied safety profile with common side effects including nausea, vomiting, and mild gastrointestinal discomfort, particularly during dose escalation
  • Available through Cured Pharmacy with a free private prescription and UK-based prescriber review

If you are considering Mounjaro, it is important to understand that the treatment works best when you make sustainable dietary changes alongside it. The medication reduces hunger significantly, which naturally leads to lower calorie consumption — but having a plan for what you eat when you are less hungry will maximise your long-term results.

Orlistat and Alli: Oral Weight Loss Treatment Explained

For those who prefer an oral medication or who do not meet the criteria for injectable treatments, orlistat remains a well-established and clinically validated option. Orlistat 120mg is available on NHS prescription or privately, and it has been in use in the UK for over two decades. Its mechanism is simple: it inhibits pancreatic and gastric lipase enzymes in the digestive system, meaning that approximately 30% of the fat you consume passes through the gut unabsorbed rather than being stored. This creates a meaningful calorie deficit over time without affecting appetite directly.

Clinical trials have shown that orlistat produces an average weight loss of 5 to 7% of body weight over 12 months when combined with a calorie-controlled diet. That may sound modest compared to the injectable options, but for someone weighing 100kg, that is 5 to 7kg of sustained weight loss — enough to produce measurable improvements in blood pressure, cholesterol, and blood glucose control. Many people find that the lifestyle accountability that orlistat demands actually helps embed healthier eating habits for the long term.

One important thing to understand about orlistat is its dietary requirements:

  • You must follow a reduced-fat diet — ideally no more than 30% of calories from fat per meal
  • Eating high-fat meals while taking orlistat commonly causes oily or fatty stools, urgency, and flatulence — the medication effectively punishes dietary indiscretion, which some people find motivating
  • Fat-soluble vitamins (A, D, E, and K) may be less well absorbed, so a daily multivitamin is often recommended
  • Take one capsule with each main meal, up to three times daily — it does not need to be taken if a meal contains no fat

Alli, the over-the-counter version at 60mg, is available for adults with a BMI of 28 or above. While slightly less potent than the prescription version, it provides a useful entry point for people not yet ready to pursue a prescription route. You can explore XLS Medical Weight Loss Plus tablets as a complementary OTC option if you are looking for non-prescription support alongside dietary changes.

How Much Does Weight Loss Medication Cost in the UK?

Cost is one of the most common concerns for people exploring weight loss medication, and it is a very valid one. The pricing landscape in 2026 varies considerably depending on whether you are accessing treatment through the NHS, a specialist weight management clinic, or a private online pharmacy such as Cured Pharmacy.

On the NHS, access to injectable weight loss medications like Wegovy and Mounjaro is currently limited and prioritised through specialist services and Integrated Care Boards (ICBs). Waiting times can be lengthy, and not every area of the country has equal access. Orlistat is more widely available on NHS prescription for eligible patients, usually at the standard prescription charge of £9.90 per item in England in 2026 (free for those with exemption certificates).

For private access, typical costs are as follows:

  • Mounjaro (tirzepatide) KwikPen — from £145 per month at Cured Pharmacy including a free private prescription
  • Wegovy (semaglutide) — typically £195 to £250 per month from private providers
  • Saxenda (liraglutide) — approximately £150 to £200 per month
  • Orlistat 120mg (private prescription) — typically £20 to £35 per month
  • Alli 60mg (OTC) — around £25 to £35 for 84 capsules (approximately one month's supply)

Many people find the cost of Mounjaro entirely justifiable when weighed against the significant health improvements it delivers and the potential long-term costs of obesity-related conditions such as type 2 diabetes, heart disease, and joint problems. Cured Pharmacy offers competitive pricing alongside a streamlined online consultation process managed by UK-registered prescribers.

It is also worth considering that some private health insurance policies now include coverage for weight loss medication — worth checking with your insurer before committing to out-of-pocket costs.

Getting the Most From Your Weight Loss Treatment

No weight loss medication works in isolation. The most successful patients are those who treat their prescription as one component of a broader lifestyle transformation rather than a standalone solution. GLP-1 and GIP receptor agonists like Mounjaro make this easier by dramatically reducing hunger, which creates a natural window to establish healthier eating patterns without the constant battle against cravings that so many people experience unaided.

There are also important considerations around your broader health that medication cannot address alone. For instance, if you have an underactive thyroid, this can significantly hinder weight loss regardless of the medication you are taking — it may be worth exploring a thyroid test to rule out hormonal contributions to your weight challenges before or during treatment.

Practical steps that maximise your weight loss results alongside medication include:

  • Eating a protein-rich diet to preserve lean muscle mass as you lose fat — aim for at least 1.2g of protein per kg of body weight daily
  • Staying well hydrated, which supports metabolism and can reduce medication-related nausea
  • Incorporating regular physical activity — even 30 minutes of brisk walking five days per week produces meaningful metabolic benefits
  • Getting consistent sleep of seven to nine hours per night, as poor sleep elevates ghrelin (the hunger hormone) and undermines the appetite-suppressing effects of GLP-1 medications
  • Attending regular follow-ups with your prescriber to track progress, adjust doses, and address any side effects promptly
  • Using behavioural support tools such as food diaries, weight tracking apps, or group support programmes to reinforce healthy habits

For those experiencing digestive discomfort while on weight loss medication — a common side effect, particularly in the early weeks — it is also useful to support your gut health. You may wish to look at products like XLS Medical Direct Fat Binder sachets, which can complement your dietary adjustments during the earlier phases of treatment.

Side-by-Side Weight Loss Medication Comparison Table

Medication Type Administration Average Weight Loss Prescription Required? Approximate Monthly Cost (Private)
Mounjaro (Tirzepatide) Dual GIP/GLP-1 agonist Weekly injection Up to 22.5% Yes From £145
Wegovy (Semaglutide 2.4mg) GLP-1 receptor agonist Weekly injection Up to 15% Yes From £195
Saxenda (Liraglutide 3mg) GLP-1 receptor agonist Daily injection Up to 8% Yes From £150
Orlistat 120mg Lipase inhibitor Oral capsule (3x daily) 5–7% Yes From £20
Alli (Orlistat 60mg) Lipase inhibitor Oral capsule (3x daily) 3–5% No (OTC) From £25
Formoline L112 Dietary fibre supplement Oral tablet Modest (diet support) No (OTC) From £15

For a non-prescription supplement option, Formoline L112 tablets are worth noting as a dietary fibre-based fat binder that some people use alongside lifestyle changes for modest additional support, though they should not be considered equivalent to prescription medications in terms of clinical evidence.

Key Takeaways

  • Mounjaro (tirzepatide) offers the highest average weight loss of any MHRA-licensed medication in the UK, with up to 22.5% body weight reduction in clinical trials — making it the strongest option currently available in 2026
  • Wegovy and Saxenda are also effective injectable options with strong evidence, and may suit patients for whom Mounjaro is contraindicated or unavailable
  • Orlistat and Alli are oral alternatives with more modest effects but remain clinically valid, particularly for those who prefer tablets over injections
  • Eligibility is based on BMI and health conditions — private prescriptions are typically more accessible than NHS routes, with consultations available online in minutes
  • All weight loss medications work best when combined with sustainable dietary changes, regular physical activity, adequate sleep, and ongoing clinical review

When to Seek Professional Advice

Weight loss medication is a medical intervention, not a consumer product, and there are circumstances where speaking to a qualified clinician is not just advisable but essential. You should seek professional advice before starting any treatment if you have a history of pancreatitis, gallbladder disease, medullary thyroid carcinoma, or a personal or family history of multiple endocrine neoplasia type 2. If you are taking medications for type 2 diabetes, blood pressure, or thyroid conditions, your prescriber needs to know before adjusting your weight loss treatment.

You should also contact your prescriber or GP promptly if you experience any of the following during treatment:

  • Severe or persistent abdominal pain that radiates to the back (possible sign of pancreatitis)
  • Rapid heart rate or palpitations
  • Severe nausea or vomiting that prevents you from eating or drinking adequately
  • Changes in vision or unexplained swelling
  • Signs of allergic reaction including swelling of the lips, tongue, or throat
  • Low blood glucose symptoms if you are also on diabetic medication

For most people, weight loss medication is well tolerated and the benefits significantly outweigh the risks when used under appropriate clinical supervision. The key is to work with a registered UK prescriber who reviews your case individually rather than relying on unregulated online sources.

Scientific References

  1. Jastreboff AM, et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. SURMOUNT-1 Trial. [Accessed 12 August 2026]
  2. NICE Technology Appraisal Guidance TA875 (2023). Semaglutide for managing overweight and obesity. National Institute for Health and Care Excellence. [Accessed 12 August 2026]
  3. NHS England and UK Health Security Agency. Obesity: Guidance for commissioners and providers. GOV.UK. [Accessed 12 August 2026]
  4. NICE Technology Appraisal TA875: Semaglutide for managing overweight and obesity, NICE, 2023 [Accessed 12 August 2026]
  5. Wegovy 2.4mg solution for injection – Summary of Product Characteristics, electronic Medicines Compendium (EMC), 2023 [Accessed 12 August 2026]
  6. Wilding JPH et al., Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 trial), The Lancet, 2021 [Accessed 12 August 2026]
  7. NICE Clinical Guideline CG189: Obesity: identification, assessment and management, NICE, 2014 (updated 2023) [Accessed 12 August 2026]
  8. Report on the Epidemiology of Obesity in England, Office for Health Improvements and Disparities (OHID), DHSC, 2022 [Accessed 12 August 2026]
  9. Batterham RL et al., Orlistat in the management of obesity: a review of its clinical use, Diabetes, Obesity and Metabolism, 2021 [Accessed 12 August 2026]

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today.

Once you complete a short online assessment, you will be able to choose your preferred treatment and quantity from a list of safe, medically approved options tailored to you.

Start My AssessmentReturning Customer?Log In to Your Account

Frequently Asked Questions

How long does it take for weight loss medication to start working in the UK?

How long weight loss medication takes to work in the UK varies by treatment. Mounjaro and Wegovy typically produce noticeable results within four to eight weeks, with significant weight loss at around three to six months. Orlistat can reduce fat absorption from the first dose, but meaningful weight changes are usually visible after twelve weeks of consistent use alongside a calorie-controlled diet.

Is Mounjaro safe for long-term use in the UK?

Mounjaro is considered safe for long-term use in the UK based on current clinical evidence. It is MHRA-approved and has been studied in large-scale trials showing sustained safety over 72 weeks. As with any prescription medication, long-term use should be monitored by a qualified prescriber who can assess ongoing suitability, adjust doses, and review any side effects that develop over time.

Can you take Orlistat with other medications in the UK?

Taking Orlistat with other medications in the UK requires care, as it can interact with several drugs including ciclosporin, anticoagulants like warfarin, and thyroid medications. Orlistat may reduce the absorption of fat-soluble vitamins and some prescription drugs. Always inform your prescriber or pharmacist of all medications you are currently taking before starting Orlistat to ensure it is safe for you.

What is the dose of Mounjaro for weight loss in the UK?

The starting dose of Mounjaro for weight loss in the UK is 2.5mg once weekly, injected subcutaneously. The dose is gradually increased every four weeks, typically moving through 5mg, 7.5mg, 10mg, 12.5mg, and up to a maximum maintenance dose of 15mg weekly. Dose escalation should always be guided by a qualified prescriber based on individual tolerance and clinical response.

Back to blog